Get started
Author

Christina Kapizioni

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
2024 · Hannah Gordon, Silvia Minozzi, et al. · Journal of Crohn s and Colitis · 442
PDF
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
2022 · Hannah Gordon, Livia Biancone, et al. · Journal of Crohn s and Colitis · 336
PDF
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
2024 · Michel Adamina, Silvia Minozzi, et al. · Journal of Crohn s and Colitis · 217
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
2023 · Christina Kapizioni, Rofaida Desoki, et al. · Journal of Crohn s and Colitis · 142
PDF
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
2022 · Simeng Lin, Nicholas A. Kennedy, et al. · Nature Communications · 103
PDF
Results of the Eighth Scientific Workshop of ECCO: Prevention and Treatment of Postoperative Recurrence in Patients With Crohn’s Disease Undergoing an Ileocolonic Resection With Ileocolonic Anastomosis
2023 · Marc Ferrante, Lieven Pouillon, et al. · Journal of Crohn s and Colitis · 43
PDF
Results of the Eighth Scientific Workshop of ECCO: Diagnosing Postoperative Recurrence of Crohn’s Disease After an Ileocolonic Resection With Ileocolonic Anastomosis
2023 · Gabriele Dragoni, Mariangela Allocca, et al. · Journal of Crohn s and Colitis · 38
PDF
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
2022 · Zhigang Liu, Kaixing Le, et al. · The Lancet. Gastroenterology & hepatology · 35
Prevention of Malaria Resurgence in Greece through the Association of Mass Drug Administration (MDA) to Immigrants from Malaria-Endemic Regions and Standard Control Measures
2015 · Maria Tseroni, Agoritsa Baka, et al. · PLoS neglected tropical diseases · 33
PDF
Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and Risk Factors of Postoperative Crohn’s Disease Recurrence after an Ileocolonic Resection
2023 · Pauline Rivière, Gabriele Bislenghi, et al. · Journal of Crohn s and Colitis · 28
PDF
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort
2021 · Giorgos Bamias, Georgios Kokkotis, et al. · Digestive Diseases and Sciences · 23
PDF
Simulators and training models for diagnostic and therapeutic gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review
2025 · Ian M. Gralnek, Lorenzo Fuccio, et al. · Endoscopy · 22
PDF
Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn’s disease
2017 · Ioannis Papaconstantinou, Christina Kapizioni, et al. · World Journal of Gastrointestinal Pharmacology and Therapeutics · 21
PDF
EUS-Guided Diagnosis of Gastric Subepithelial Lesions, What Is New?
2023 · Thomas Vasilakis, Dimitrios Ziogas, et al. · Diagnostics · 18
PDF
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
2026 · Javier P Gisbert, María Chaparro, et al. · Journal of Crohn s and Colitis · 15
The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
2021 · Kalliopi Foteinogiannopoulou, Konstantinos Karmiris, et al. · BMC Gastroenterology · 15
PDF
Revealing Insights: A Comprehensive Overview of Gastric Outlet Obstruction Management, with Special Emphasis on EUS-Guided Gastroenterostomy
2024 · Dimitrios Ziogas, Thomas Vasilakis, et al. · Medical Sciences · 13
PDF
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
2026 · Henit Yanai, Pierre Ellul, et al. · Journal of Crohn s and Colitis · 12
PDF
Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study
2019 · Christina Kapizioni, Georgios Koutoufaris, et al. · European Journal of Gastroenterology & Hepatology · 11
Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis
2019 · P. Kourkoulis, C. Kapizioni, et al. · European Journal of Gastroenterology & Hepatology · 9
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
2026 · Michel Adamina, Peter Kienle, et al. · Journal of Crohn s and Colitis · 4
Gastric polyps: a retrospective cohort analysis of 23,668 endoscopies indicates changing epidemiological and phenotypic characteristics
2024 · Christina Kapizioni, Panagiotis Kourkoulis, et al. · Gastroenterology Review · 4
PDF
DOP74 Comparative effectiveness of vedolizumab and ustekinumab in Crohn’s Disease patients who failed anti-TNF treatment: Interrogating 1019 patients from the UK IBD BioResource
2022 · R Desoki, K Balendran, et al. · Journal of Crohn s and Colitis · 3
PDF
Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease
2026 · Marie Truyens, Xenia Tolstoy, et al. · Journal of Crohn s and Colitis · 1
PDF
Is Ustekinumab the best treatment option in patients with Crohn's disease and coexistent multiple sclerosis?
2019 · C Kapizioni, K Makris, et al. · PubMed · 1
Works count: 40
Citation count: 1,604
H-index: 15
I10-index: 20
Year
Topic
Type